BNQL.DE vs. CD91.DE
BNQL.DE (BNP Paribas Palladium ETC) and CD91.DE (Amundi NYSE Arca Gold Bugs UCITS ETF Dist) are both exchange-traded funds - BNQL.DE is a Precious Metals fund tracking the Palladium Spot Price, while CD91.DE is a Gold fund tracking the NYSE Arca Gold BUGS. Both are passively managed. Over the past 5 years, BNQL.DE returned -14.19%/yr vs 20.17%/yr for CD91.DE. At a 0.33 correlation, their price movements are largely independent. BNQL.DE charges 0.99%/yr vs 0.65%/yr for CD91.DE.
Performance
BNQL.DE vs. CD91.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BNQL.DE achieves a -17.76% return, which is significantly lower than CD91.DE's 2.09% return.
BNQL.DE
- 1D
- -1.06%
- 1M
- -11.56%
- YTD
- -17.76%
- 6M
- -8.41%
- 1Y
- 29.07%
- 3Y*
- -5.67%
- 5Y*
- -14.19%
- 10Y*
- —
CD91.DE
- 1D
- 0.92%
- 1M
- -0.47%
- YTD
- 2.09%
- 6M
- 9.79%
- 1Y
- 67.95%
- 3Y*
- 40.18%
- 5Y*
- 20.17%
- 10Y*
- 12.49%
BNQL.DE vs. CD91.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BNQL.DE BNP Paribas Palladium ETC | -17.76% | 58.42% | -16.10% | -40.26% | -4.34% | -10.11% | 10.43% | 53.40% | 21.86% | 38.20% |
CD91.DE Amundi NYSE Arca Gold Bugs UCITS ETF Dist | 2.09% | 132.40% | 20.73% | 2.42% | -1.60% | -8.06% | 15.38% | 49.81% | -12.27% | -11.24% |
Correlation
The correlation between BNQL.DE and CD91.DE is 0.46, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.46 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.41 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.40 |
Correlation (All Time) Calculated using the full available price history since Dec 12, 2016 | 0.33 |
The correlation between BNQL.DE and CD91.DE shifts across timeframes, from 0.33 (all time) to 0.46 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BNQL.DE vs. CD91.DE — Risk / Return Rank
BNQL.DE
CD91.DE
BNQL.DE vs. CD91.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for BNP Paribas Palladium ETC (BNQL.DE) and Amundi NYSE Arca Gold Bugs UCITS ETF Dist (CD91.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BNQL.DE | CD91.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.97 | ||
| Sortino ratioReturn per unit of downside risk | -0.92 | ||
| Omega ratioGain probability vs. loss probability | 1.14 | 1.27 | -0.13 |
| Calmar ratioReturn relative to maximum drawdown | 0.78 | 2.49 | -1.71 |
| Martin ratioReturn relative to average drawdown | 1.68 | 6.17 | -4.50 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BNQL.DE | CD91.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.63 | 1.60 | -0.97 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.31 | 0.58 | -0.89 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.36 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.11 | 0.09 | +0.02 |
Drawdowns
BNQL.DE vs. CD91.DE - Drawdown Comparison
The maximum BNQL.DE drawdown since its inception was -73.80%, smaller than the maximum CD91.DE drawdown of -80.32%. Use the drawdown chart below to compare losses from any high point for BNQL.DE and CD91.DE.
Loading charts...
Drawdown Indicators
| BNQL.DE | CD91.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -73.80% | -80.32% | +6.52% |
Max Drawdown (1Y)Largest decline over 1 year | -37.28% | -27.16% | -10.12% |
Max Drawdown (3Y)Largest decline over 3 years | -43.58% | -27.16% | -16.42% |
Max Drawdown (5Y)Largest decline over 5 years | -73.80% | -39.56% | -34.24% |
Max Drawdown (10Y)Largest decline over 10 years | — | -55.46% | — |
Current DrawdownCurrent decline from peak | -61.09% | -23.41% | -37.68% |
Average DrawdownAverage peak-to-trough decline | -32.15% | -46.60% | +14.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.30% | 10.95% | +6.35% |
Volatility
BNQL.DE vs. CD91.DE - Volatility Comparison
The current volatility for BNP Paribas Palladium ETC (BNQL.DE) is 10.31%, while Amundi NYSE Arca Gold Bugs UCITS ETF Dist (CD91.DE) has a volatility of 13.40%. This indicates that BNQL.DE experiences smaller price fluctuations and is considered to be less risky than CD91.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BNQL.DE | CD91.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.31% | 13.40% | -3.09% |
Volatility (6M)Calculated over the trailing 6-month period | 37.75% | 33.89% | +3.86% |
Volatility (1Y)Calculated over the trailing 1-year period | 45.71% | 42.29% | +3.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.30% | 34.31% | +10.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 40.77% | 34.40% | +6.37% |
BNQL.DE vs. CD91.DE - Expense Ratio Comparison
BNQL.DE has a 0.99% expense ratio, which is higher than CD91.DE's 0.65% expense ratio.
Dividends
BNQL.DE vs. CD91.DE - Dividend Comparison
BNQL.DE has not paid dividends to shareholders, while CD91.DE's dividend yield for the trailing twelve months is around 0.13%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
BNQL.DE BNP Paribas Palladium ETC | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CD91.DE Amundi NYSE Arca Gold Bugs UCITS ETF Dist | 0.13% | 0.14% | 0.31% | 2.37% | 1.05% | 0.46% | 0.14% | 0.30% | 0.00% | 0.57% |
Frequently Asked Questions
BNQL.DE and CD91.DE have a correlation of 0.46, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, CD91.DE is cheaper at 0.65% per year. The better choice depends on whether you care most about return, fees, risk, or income.
CD91.DE is cheaper with a 0.65% expense ratio, compared with 0.99% for BNQL.DE.
BNQL.DE is categorized as Precious Metals, while CD91.DE is Gold. BNQL.DE tracks Palladium Spot Price, while CD91.DE tracks NYSE Arca Gold BUGS. They also come from different issuers: BNP Paribas and Amundi. Their fees differ too: 0.99% for BNQL.DE and 0.65% for CD91.DE.
Find the right allocation for BNQL.DE and CD91.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer